Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts

AIDS Patient Care and STDs

Volumn 22, Issue 12, 2008, Pages 977-987

  Merzel, Cheryl ^a   VanDevanter, Nancy ^b   Irvine, Mary ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c Mailman School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; CAREGIVER; CHILD; CHILD BEHAVIOR; CHILD CARE; CHILD PARENT RELATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; QUALITATIVE ANALYSIS; SCHOOL CHILD; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CAREGIVERS; CHILD; FEMALE; GOVERNMENT PROGRAMS; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; PSYCHOLOGY;

EID: 57449117709     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0048     Document Type: Article

References (49)

1. Centers for Disease Control and Prevention. HIV/AIDS Statistics and Surveillance. www.cdc.gov/hiv/topics/surveillance/basic.htm#hivaidsexposure (Last accessed June 9, 2008).
2. Gortmaker S, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2008;345:1522-1528.
3. Murphy E, Collier A, Kalish L, et al. Highly active retroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26.
4. Watson D, Farley J. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1999;18:682-689.
5. Melvin A, Frenkel L. Pediatric human immunodeficiency virus type 1 infection: Updates on prevention and management. AIDS Clin Rev 2000-2001;63-83.
6. Sullivan J, Luzuriaga K. The changing face of pediatric HIV-1 infection. N Engl J Med 2008;345:1568-1569.
7. Centers for Disease Control and Prevention. Cases of HIV Infection and AIDS in the United States and Dependent Areas,2006.www.cdc.gov/hiv/ topicssurveillance/resources/reports/2006report/table8.htm. (Last accessed June 9, 2008.
8. Abrams E, Weedon J, Bertolli J, et al. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. Pediatr Infect Dis J 2001;20:511-517.
9. Ledlie S. The psychosocial issues of children with perinatally acquired HIV disease becoming adolescents: A growing challenge for providers. AIDS Patient Care STDs 2001;15:231-236.
10. Chesney M. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30(Suppl 2):S171-S176.
11. Ickovics J, Meade C. Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care 2002;14:309-318.
12. Steele R, Grauer D. Adherence to antiretroviral therapy for pediatric HIV infection: Review of the literature and recommendations for research. Clin Child Fam Psychol Rev 2003;6:17-30.
13. Simoni J, Frick P, Pantalone D, Turner B. Antiretroviral adherence interventions: A review of current literature and ongoing studies. Top HIV Med 2003;11:185-198.
14. Battles H, Wiener L. From adolescence through young adulthood: Psychosocial adjustment associated with long-term survival of HIV. J Adolesc Health 2002;30:161-168.
15. Mellins C, Brackis-Cott E, Dolezal C, Abrams E. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004;23:1035-1041.
16. Murphy D, Wilson C, Durako S, Muenz L, Belzer M, Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH-HIV-infected adolescent cohort in the USA. AIDS Care 2001;13:27-40.
17. Williams P, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics 2006;118:1745-1757.
18. Goode M, McMaugh A, Crisp J, Wales S, Ziegler J. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care 2003;15:403-408.
19. Pontali E, Feasi M, Toscannini R, et al. Adherence to combination antiretroviral treatment in children. HIV Clin Trials 2001;2:466-473.
20. Van Dyke R, Lee S, Johnson G, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002;109:1-7.
21. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J 2000;19:1148-1153.
22. Byrne M, Honig J, Jurgrau A, Heffernan S, Donahue M. Achieving adherence with antiretroviral medications for pediatric HIV disease. AIDS Read 2002;12:164.
23. Murphy D, Sarr M, Durako S, Mosciki A, Wilson C, Muenz L. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med 2003;157:249-255.
24. Belzer M, Fuchs D, Luftman G, Tucker D. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health 1999;25:316-319.
25. Lyon M, Trexler C, Akpan-Townsend C, et al. A family group approach to increasing adherence to therapy in HIV-infected youths: Results of a pilot project. AIDS Patient Care STDs 2003;17:299-308.
26. Hammami N, Nostlinger C, Hoeree T, Lefevre P, Jonckheer T, Kolsteren P. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study. Pediatrics 2004;114:591-597.
27. Brown L, Lourie K, Pao M. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry 2000;41:81-96.
28. Mellins C, Ehrhardt A. Families affected by pediatric acquired immunodeficiency syndrome: Sources of stress and coping. J Dev Behav Pediatr 1994;15(Suppl 3):S54-S60.
29. Hansell P, Hughes C, Caliandro G, et al. Boosting social support in caregivers of children with HIV/AIDS. AIDS Patient Care STDs 1999;5:297-302.
30. Hough E, Brumitt G, Templin T, Saltz E, Mood D. A model of mother-child coping and adjustment to HIV. Soc Sci Med 2003;56:643-655.
31. Lewis S, Haiken H, Hoyt L. Living beyond the odds: A psychosocial perspective on long-term survivors of pediatric human immunodeficiency virus infection. J Dev Behav Pediatr 1994;15:S12-S17.
32. Simoni J, Montgomery A, Martin E, New M, Demas P, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management. Pediatrics 2007;119:1371-1383.
33. Mellins C, Brackis-Cott E, Dolezal C, Richards A, Nicholas S, Abrams E. Patterns of HIV status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatry 2002;7:101-114.
34. Martin S, Elliott-DeSorbo D, Wolters P, et al. Patient, caregiver, and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatr Infect Dis J 2007;26:61-67.
35. Prochaska J, Velicer W. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38-48.
36. ATLAS.ti. Berlin: Scientific Software Development, 1997.
37. Wrubel J, Moskowitz J, Richards T, Prakke H, Acree M, Folkman S. Pediatric adherence: perspectives of mothers of children with HIV. Soc Sci Med 2005;61:2423-2433.
38. Secord E, Cotronei-Cascardo C. Pediatric and adolescent HIV disease. Ann Allergy Asthma Immunol 2007;98:405-413.
39. Veinot T, Flynn P, Skinner H, et al. "Supposed to make you better but it doesn't really": HIV positive youths' perceptions of HIV treatment. J Adol Health 2006;38:261-267.
40. Ammassari A, Trotta M, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. J Acquir Immune Defic Syndr 2002;31(Suppl 3):S123-S127.
41. Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:124-133.
42. Remien R, Hirky A, Johnson M, Weinhardt L, Whittier D, Le G. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS Behav 2003;7:61-72.
43. Simoni J, Frick P, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol 2006;25:74-81.
44. Singh N, Berman S, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-830.
45. DiMatteo M. Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol 2004;23:207-218.
46. Gonzalez J, Penedo F, Antoni M, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol 2004;23:413-418.
47. Poindexter C, Linsk N. "I'm just glad that I'm here": Stories of seven African-American HIV-affected grandmothers. J Gerontol Soc Work 1999;32:63-81.
48. Steele R, Nelson T, Cle B. Psychosocial functioning of children with AIDS and HIV infection: Review of the literature from a socioecological framework. J Dev Behav Pediatr 2007;28:58-69.
49. Bachanas P, Kullgren K, Schwartz K, et al. Predictors of psychological adjustment in school-age children infected with HIV. J Pediatr Psychol 2001;26:343-352.